drugset / Trial / NCT03943576
Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of the investigators study was to investigate the safety and efficacy of allogeneic ADSCs for the clinical treatment of knee osteoarthritis.
Timeline
- Start
- 2019-12-01
- Primary completion
- 2022-04-27
- Completion
- 2023-03-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GXCPC1 | Cell therapy | 6.7e+06 cells | Other |
| Subject | GXCPC1 | Cell therapy | 4e+07 cells | Other |